Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Editor's pick
CATIE
2 November 2012
New & experimental HIV treatments

Gilead: HIV drug meets key Phase 2 trial objective

Editor's pick
Gilead press release
31 October 2012
How HIV works

Groundbreaking Research Discovers Possible New Way To Fight HIV

Editor's pick
Medical News Today
25 October 2012
New & experimental HIV treatments

Invisible RNAs as Anti-HIV Drug Targets

Editor's pick
Genetic Engineering News
10 October 2012
Starting treatment

Thalidomide for HIV-Related IRIS Shows Promise

Editor's pick
AIDSMeds
24 September 2012
New & experimental HIV treatments

Stribild (a.k.a. "Quad") Performs Well for People Over 50, Study Finds

Editor's pick
The Body
24 September 2012
Health services & systems

South Africa to open US$8 million HIV, TB facility

Editor's pick
SciDevNet
21 September 2012
New & experimental HIV treatments

Avexa’s HIV integrase inhibitors show activity against drug-resistant HIV with potential for once-daily dosing

Editor's pick
Avexa press release
20 September 2012
Treatment guidelines

Stribild Receives ‘Alternative’ U.S. Guidelines Ranking

Editor's pick
AIDSMeds
19 September 2012
New & experimental HIV treatments

HIV Drug Consortium Wins €4M EU Funding

Editor's pick
Genetic Engineering News
18 September 2012
Pharmaceutical industry

Gilead's HIV pill could be market leader in 3-5 years: JP Morgan

Editor's pick
CNBC
18 September 2012
New & experimental HIV treatments

Long-acting integrase inhibitor S/GSK1265744 active against multiple HIV subtypes

News
17 September 2012
New & experimental HIV treatments

Dolutegravir combo beats Atripla for effectiveness and tolerability

News
14 September 2012
New & experimental HIV treatments

New HIV Drugs Promising but Unworkable

Editor's pick
MedPage Today
14 September 2012
New & experimental HIV treatments

Long-Lasting HIV Drug Could Change Therapy

Editor's pick
MedPage Today
13 September 2012
New & experimental HIV treatments

Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

News
12 September 2012
New & experimental HIV treatments

Long-acting fusion inhibitor albuvirtide looks promising in early studies

News
11 September 2012
Pharmaceutical industry

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Editor's pick
Seeking Alpha
6 September 2012
HIV treatment for children & young people

World's first HIV/AIDS nanomedicines

Editor's pick
Hospital Pharmacy Europe
3 September 2012
Pharmaceutical industry

Quad approved in US: exorbitant cost likely to block use in Europe

Editor's pick
HIV i-Base
28 August 2012
New & experimental HIV treatments

F.D.A. Approves Once-a-Day Pill for H.I.V.

Editor's pick
New York Times
28 August 2012
New & experimental HIV treatments

Attachment inhibitor BMS-663068 does well in early study involving HIV-positive people

News
28 August 2012
The search for an HIV prevention vaccine

Drug improves vaccine response in HIV patients

Editor's pick
Imperial College London press release.
24 August 2012
Pharmaceutical industry

AIDS pill's price tag draws criticism

Editor's pick
San Francisco Chronicle
24 August 2012